Texas Biotech (TXB) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew R. Sicotte who started this subject	8/11/2000 11:06:19 AM
From: opalapril	Read Replies (1) of 834

Texas Biotechnology Reports Second Quarter Financial Results; Cites Achievement of Major Corporate Objectives siliconinvestor.com David B. McWilliams, President and Chief Executive Officer of Texas Biotechnology stated, "The accomplishments we have achieved during the past few months have fundamentally changed our Company. Through the approval of argatroban, the formation of several strategic and diversified alliances, and a healthy cash position, we are now in a much stronger position to move the Company towards profitability and build sustainable shareholder value."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next